- $841.43m
- $814.51m
- $245.29m
Graham Corp expected to post a loss of 3 cents a share - Earnings Preview
Brief: Graham Corp - Amendment To Its Five-Year Term Loan And Line Of Credit Agreement Suspended Financial Covenants Through September 30
Brief: Graham Corp Says Alan Fortier Will Remain In Chair Of Nominating And Governance Committee
Brief: Graham Corporation Names Christopher Thome As Chief Financial Officer
Brief: Graham Reports Q3 Loss Per Share $0.35
Graham Corp expected to post earnings of 21 cents a share - Earnings Preview
Graham Corp expected to post earnings of 21 cents a share - Earnings Preview
Graham Corp reports results for the quarter ended in September - Earnings Summary
Brief: Graham Q2 Loss Per Share $0.05
Graham Corp expected to post earnings of 5 cents a share - Earnings Preview
Brief: Graham Corp Awarded Over $20 Mln In Orders To Date In Q2 2022
U.S. STOCKS ON THE MOVE-Katapult, PharmaCyte Biotech, Fulcrum Therapeutics
Graham Corp falls after downbeat results
Graham Corp reports results for the quarter ended in June - Earnings Summary
Brief: Graham Corporation Appoints Daniel Thoren As President And Chief Executive Officer
Brief: Graham Corporation Reports Fiscal 2022 First Quarter Results
Graham Corp expected to post a loss of 5 cents a share - Earnings Preview
Graham Corp expected to post a loss of 5 cents a share - Earnings Preview
Graham Corp reports results for the quarter ended in March - Earnings Summary